Integrated Core Strategies (US) LLC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-01 4:21 pm Purchase |
2024-04-25 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 4,544,150 5.000% |
50,889 (+1.13%) |
Filing |
| 2024-04-25 4:18 pm Purchase |
2024-04-17 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 4,493,261 4.970% |
931,924 (+26.17%) |
Filing |
| 2024-01-23 4:31 pm Sale |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 3,561,337 4.000% |
-699,704 (-16.42%) |
Filing |
| 2023-10-17 4:14 pm Purchase |
2023-10-10 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 4,261,041 5.200% |
4,261,041 (New Position) |
Filing |